Cigna Group
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B |
| Selling, general & administrative | $14.6B | $14.8B | $14.8B | $13.2B | $13.0B |
| Operating income | $9.2B | $9.4B | $8.5B | $8.4B | $7.9B |
| Pretax income | $7.8B | $5.3B | $5.5B | $8.4B | $6.8B |
| Income tax expense | $1.5B | $1.5B | $141.0M | $1.6B | $1.4B |
| Net income | $6.0B | $3.4B | $5.2B | $6.8B | $5.4B |
| Balance Sheet | |||||
| Cash and equivalents | $7.7B | $7.5B | $7.8B | $5.9B | $5.1B |
| Current assets | $47.8B | $48.9B | $37.4B | $30.1B | $36.1B |
| Total assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B |
| Current liabilities | $56.3B | $58.0B | $48.7B | $41.2B | $43.6B |
| Total liabilities | $116.0B | $114.6B | $106.4B | $99.1B | $107.7B |
| Stockholders' equity | $41.7B | $41.0B | $46.2B | $44.7B | $47.1B |
| Cash Flow Statement | |||||
| Cash from operations | $9.6B | $10.4B | $11.8B | $8.7B | $7.2B |
| Depreciation and amortization | $2.8B | $2.8B | $3.0B | $2.9B | $2.9B |
| Stock-based compensation | $291.0M | $308.0M | $286.0M | $264.0M | $268.0M |
| Dividends paid | $1.6B | $1.6B | $1.4B | $1.4B | $1.3B |
| Share repurchases | $3.6B | $7.0B | $2.3B | $7.6B | $7.7B |
Shares outstanding 264.5M · Free float 99.4%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.
Recent filings
- May 13, 2026 8-K
- April 30, 2026 10-Q
- April 30, 2026 8-K
- April 27, 2026 8-K
- March 3, 2026 8-K
- February 27, 2026 8-K
- February 26, 2026 10-K
- February 5, 2026 8-K